Process analytics is one of the popular research domains that advanced in the recent years.Process analytics encompasses identification,monitoring,and improvement of the processes through knowledge extraction from his...Process analytics is one of the popular research domains that advanced in the recent years.Process analytics encompasses identification,monitoring,and improvement of the processes through knowledge extraction from historical data.The evolution of Artificial Intelligence(AI)-enabled Electronic Health Records(EHRs)revolutionized the medical practice.Type 2 Diabetes Mellitus(T2DM)is a syndrome characterized by the lack of insulin secretion.If not diagnosed and managed at early stages,it may produce severe outcomes and at times,death too.Chronic Kidney Disease(CKD)and Coronary Heart Disease(CHD)are the most common,long-term and life-threatening diseases caused by T2DM.There-fore,it becomes inevitable to predict the risks of CKD and CHD in T2DM patients.The current research article presents automated Deep Learning(DL)-based Deep Neural Network(DNN)with Adagrad Optimization Algorithm i.e.,DNN-AGOA model to predict CKD and CHD risks in T2DM patients.The paper proposes a risk prediction model for T2DM patients who may develop CKD or CHD.This model helps in alarming both T2DM patients and clinicians in advance.At first,the proposed DNN-AGOA model performs data preprocessing to improve the quality of data and make it compatible for further processing.Besides,a Deep Neural Network(DNN)is employed for feature extraction,after which sigmoid function is used for classification.Further,Adagrad optimizer is applied to improve the performance of DNN model.For experimental validation,benchmark medical datasets were used and the results were validated under sev-eral dimensions.The proposed model achieved a maximum precision of 93.99%,recall of 94.63%,specificity of 73.34%,accuracy of 92.58%,and F-score of 94.22%.The results attained through experimentation established that the pro-posed DNN-AGOA model has good prediction capability over other methods.展开更多
文摘Process analytics is one of the popular research domains that advanced in the recent years.Process analytics encompasses identification,monitoring,and improvement of the processes through knowledge extraction from historical data.The evolution of Artificial Intelligence(AI)-enabled Electronic Health Records(EHRs)revolutionized the medical practice.Type 2 Diabetes Mellitus(T2DM)is a syndrome characterized by the lack of insulin secretion.If not diagnosed and managed at early stages,it may produce severe outcomes and at times,death too.Chronic Kidney Disease(CKD)and Coronary Heart Disease(CHD)are the most common,long-term and life-threatening diseases caused by T2DM.There-fore,it becomes inevitable to predict the risks of CKD and CHD in T2DM patients.The current research article presents automated Deep Learning(DL)-based Deep Neural Network(DNN)with Adagrad Optimization Algorithm i.e.,DNN-AGOA model to predict CKD and CHD risks in T2DM patients.The paper proposes a risk prediction model for T2DM patients who may develop CKD or CHD.This model helps in alarming both T2DM patients and clinicians in advance.At first,the proposed DNN-AGOA model performs data preprocessing to improve the quality of data and make it compatible for further processing.Besides,a Deep Neural Network(DNN)is employed for feature extraction,after which sigmoid function is used for classification.Further,Adagrad optimizer is applied to improve the performance of DNN model.For experimental validation,benchmark medical datasets were used and the results were validated under sev-eral dimensions.The proposed model achieved a maximum precision of 93.99%,recall of 94.63%,specificity of 73.34%,accuracy of 92.58%,and F-score of 94.22%.The results attained through experimentation established that the pro-posed DNN-AGOA model has good prediction capability over other methods.
